Neurociencias
Departamento
Medical University of Vienna
Viena, AustriaPublicaciones en colaboración con investigadoras/es de Medical University of Vienna (28)
2024
-
Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis (Journal of Neurology, (2023), 270, 12, (5849-5865), 10.1007/s00415-023-11862-4)
Journal of Neurology
-
PsyCog: A computerised mini battery for assessing cognition in psychosis
Schizophrenia Research: Cognition, Vol. 37
2023
-
Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis
Journal of Neurology, Vol. 270, Núm. 12, pp. 5849-5865
-
Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease
npj Parkinson's Disease, Vol. 9, Núm. 1
-
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
Movement Disorders, Vol. 38, Núm. 2, pp. 286-303
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis
European Psychiatry, Vol. 66, Núm. 1
-
Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome
Schizophrenia bulletin, Vol. 49, Núm. 2, pp. 339-349
2022
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842
-
Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 93, Núm. 10, pp. 1099-1111
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis
Psychological Medicine, Vol. 52, Núm. 8, pp. 1569-1577
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
2020
-
Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis
Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 823-833
-
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Nature Communications, Vol. 11, Núm. 1
2019
-
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease
PLoS Genetics, Vol. 15, Núm. 6
-
FAHN/SPG35: A narrow phenotypic spectrum across disease classifications
Brain, Vol. 142, Núm. 6, pp. 1561-1572